Nu Skin Enterprises (NYSE:NUS) Stock Rating Lowered by StockNews.com

Nu Skin Enterprises (NYSE:NUS – Get Rating) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Friday.

Other equities analysts also recently issued research reports about the company. DA Davidson increased their price target on Nu Skin Enterprises from $47.00 to $50.00 and gave the stock a “neutral” rating in a research report on Thursday, February 17th. Zacks Investment Research raised Nu Skin Enterprises from a “hold” rating to a “strong-buy” rating and set a $57.00 target price for the company in a report on Tuesday, March 29th. Jefferies Financial Group increased their target price on Nu Skin Enterprises from $61.00 to $75.00 in a report on Thursday, February 17th. Finally, TheStreet cut Nu Skin Enterprises from a “b” rating to a “c+” rating in a report on Friday, February 18th. Three research analysts have rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $60.60.

Shares of NUS stock opened at $45.02 on Friday. The company has a market capitalization of $2.24 billion, a P/E ratio of 16.67 and a beta of 1.24. The business’s 50 day moving average is $46.71 and its two-hundred day moving average is $47.74. The company has a current ratio of 1.72, a quick ratio of 0.89 and a debt-to-equity ratio of 0.28. Nu Skin Enterprises has a 12-month low of $39.40 and a 12-month high of $62.70.

Nu Skin Enterprises (NYSE:NUS – Get Rating) last issued its quarterly earnings results on Wednesday, May 4th. The company reported $0.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.72 by $0.04. The company had revenue of $604.90 million for the quarter, compared to the consensus estimate of $579.70 million. Nu Skin Enterprises had a return on equity of 22.05% and a net margin of 5.28%. Nu Skin Enterprises’s revenue for the quarter was down 10.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.91 earnings per share. On average, research analysts predict that Nu Skin Enterprises will post 3.78 earnings per share for the current fiscal year.

In related news, CEO Ryan S. Napierski sold 25,000 shares of the stock in a transaction that occurred on Friday, February 25th. The stock was sold at an average price of $47.40, for a total value of $1,185,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Andrew D. Lipman sold 1,000 shares of the stock in a transaction that occurred on Tuesday, February 22nd. The shares were sold at an average price of $53.27, for a total value of $53,270.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 28,000 shares of company stock valued at $1,333,390. Insiders own 2.80% of the company’s stock.

A number of hedge funds have recently bought and sold shares of NUS. Morgan Stanley increased its stake in Nu Skin Enterprises by 1.9% during the second quarter. Morgan Stanley now owns 360,382 shares of the company’s stock worth $20,415,000 after acquiring an additional 6,652 shares during the last quarter. Truist Financial Corp increased its stake in Nu Skin Enterprises by 2.2% during the third quarter. Truist Financial Corp now owns 23,855 shares of the company’s stock worth $965,000 after acquiring an additional 504 shares during the last quarter. BlackRock Inc. increased its stake in Nu Skin Enterprises by 0.8% during the third quarter. BlackRock Inc. now owns 5,893,635 shares of the company’s stock worth $238,516,000 after acquiring an additional 46,186 shares during the last quarter. Teacher Retirement System of Texas increased its stake in Nu Skin Enterprises by 18.2% during the third quarter. Teacher Retirement System of Texas now owns 8,193 shares of the company’s stock worth $332,000 after acquiring an additional 1,259 shares during the last quarter. Finally, Citigroup Inc. increased its stake in Nu Skin Enterprises by 59.3% during the third quarter. Citigroup Inc. now owns 34,378 shares of the company’s stock worth $1,392,000 after acquiring an additional 12,797 shares during the last quarter. 93.79% of the stock is owned by institutional investors.

Nu Skin Enterprises Company Profile (Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.

Featured Articles